The urgent need for multidisciplinary approaches in managing alcohol-associated liver disease: Editorial on "The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study".
作者信息
Kim Soon Sun, Cheong Jae Youn
机构信息
Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea.
出版信息
Clin Mol Hepatol. 2025 Jan;31(1):316-318. doi: 10.3350/cmh.2024.0847. Epub 2024 Oct 7.
Abstract
摘要
相似文献
1
The urgent need for multidisciplinary approaches in managing alcohol-associated liver disease: Editorial on "The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study".管理酒精性肝病时对多学科方法的迫切需求：关于“精神科干预对酒精性肝病的预后影响：英国生物银行队列研究”的社论
Clin Mol Hepatol. 2025 Jan;31(1):316-318. doi: 10.3350/cmh.2024.0847. Epub 2024 Oct 7.
2
The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study.精神干预对酒精相关性肝病预后的影响：英国生物库队列研究。
Clin Mol Hepatol. 2024 Oct;30(4):929-942. doi: 10.3350/cmh.2024.0278. Epub 2024 Aug 27.
3
Multidisciplinary View of Alcohol Use Disorder: From a Psychiatric Illness to a Major Liver Disease.酒精使用障碍的多学科视角：从一种精神疾病到一种主要的肝脏疾病
Biomolecules. 2016 Jan 15;6(1):11. doi: 10.3390/biom6010011.
4
A multidisciplinary approach to the management of liver disease and alcohol disorders in psychiatric settings (Review).精神科环境中肝病和酒精障碍管理的多学科方法（综述）
Exp Ther Med. 2021 Mar;21(3):271. doi: 10.3892/etm.2021.9702. Epub 2021 Jan 25.
5
Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis.大流行前的精神障碍与 COVID-19 风险：英国生物银行队列研究。
Lancet Healthy Longev. 2020 Nov;1(2):e69-e79. doi: 10.1016/S2666-7568(20)30013-1. Epub 2020 Oct 26.
6
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry.一种用于欧洲裔重度饮酒者酒精性肝硬化的多基因风险评分。
Hepatol Commun. 2024 May 10;8(6). doi: 10.1097/HC9.0000000000000431. eCollection 2024 Jun 1.
7
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis.脂蛋白脂肪酶高产生变体可能对酒精相关性肝硬化中的肝细胞癌具有保护作用。
JHEP Rep. 2023 Jan 25;5(4):100684. doi: 10.1016/j.jhepr.2023.100684. eCollection 2023 Apr.
8
Integrated Care of Alcohol-Related Liver Disease.酒精性肝病的综合治疗
J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1069-1082. doi: 10.1016/j.jceh.2022.01.010. Epub 2022 Jan 31.
9
Exploring the nexus between hypothyroidism and metabolic dysfunction-associated steatotic liver disease: a UK biobank cohort study.探索甲状腺功能减退与代谢功能障碍相关脂肪性肝病之间的联系：一项英国生物银行队列研究。
Sci Rep. 2025 Feb 25;15(1):6692. doi: 10.1038/s41598-025-91221-7.
10
Telemedicine in alcohol liver disease and transplantation care: Addiction therapy through video-conferencing-A case report.酒精性肝病与移植护理中的远程医疗：通过视频会议进行成瘾治疗——病例报告
SAGE Open Med Case Rep. 2024 Feb 25;12:2050313X241235012. doi: 10.1177/2050313X241235012. eCollection 2024.
本文引用的文献
1
The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study.精神干预对酒精相关性肝病预后的影响：英国生物库队列研究。
Clin Mol Hepatol. 2024 Oct;30(4):929-942. doi: 10.3350/cmh.2024.0278. Epub 2024 Aug 27.
2
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action.酒精相关肝病患者的酒精使用障碍治疗：创新方法和行动呼吁。
Addict Sci Clin Pract. 2024 Mar 19;19(1):19. doi: 10.1186/s13722-024-00448-8.
3
Efficacy of psychosocial interventions to reduce alcohol use in comorbid alcohol use disorder and alcohol-related liver disease: a systematic review of randomized controlled trials.心理社会干预对减少共病酒精使用障碍和酒精性肝病患者饮酒量的疗效：一项随机对照试验的系统评价。
Alcohol Alcohol. 2023 Sep 9;58(5):478-484. doi: 10.1093/alcalc/agad051.
4
Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease.心理疗法治疗酒精使用障碍与降低酒精相关性肝病发病风险相关。
Clin Gastroenterol Hepatol. 2023 Jun;21(6):1571-1580.e7. doi: 10.1016/j.cgh.2022.08.001. Epub 2022 Aug 11.
5
Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic.新型多学科酒精性肝病诊所的可行性和初步经验。
J Subst Abuse Treat. 2021 Nov;130:108396. doi: 10.1016/j.jsat.2021.108396. Epub 2021 Apr 9.
6
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis.酒精使用障碍治疗对肝硬化患者临床结局的影响。
Hepatology. 2020 Jun;71(6):2080-2092. doi: 10.1002/hep.31042. Epub 2020 May 22.
7
Advances in the science and treatment of alcohol use disorder.酒精使用障碍的科学和治疗进展。
Sci Adv. 2019 Sep 25;5(9):eaax4043. doi: 10.1126/sciadv.aax4043. eCollection 2019 Sep.
Zotero 插件